Posted by Michael Wonder on 02 Dec 2020
IQWiG publishes 1,000th report
2 December 2020 - In the 16th year of its existence, IQWiG has published its 1,000th report: a dossier assessment on bulevirtide, an orphan drug for the treatment of patients with a rare form of chronic hepatitis.
The Institute for Quality and Efficiency in Health Care (IQWiG) finalised its first report in December 2005. On behalf of the Federal Joint Committee (G-BA), the institute investigated the question of whether threshold values for minimum quantities for total knee replacement could be derived from German data.
